CD4 and cancer: We found that using the proportions of fibroblasts, epithelial cells, TIIC-like macrophages, PBMC-like CD4+T cells, and monocytes from the TIIC + PBMC approach, cancer recurrence was predicted with an AUC of 0.69 (Figure 2B).